Nanoparticles Show Potential as Transport Agents for Parkinson’s Treatments
Nanoparticles as transport agents have a potential to more effectively deliver medications to the brain, opening neurological disorders such as…
Articles by Marisa Wexler, MS
Parkinson’s Patients Have Positive Attitudes About Telemedicine During Pandemic, Survey Reveals
Most people with Parkinson’s disease have positive attitudes about telemedicine during the COVID-19 pandemic, a small Japanese study…
Wearable Device Could Monitor Multiple Aspects of Parkinson’s Symptoms
A new wearable device could enable monitoring of motor symptoms as well as electrical activity of the brain, heart, and…
Young Onset Parkinson’s Presents Unique Challenges, Article Asserts
People with young onset Parkinson’s disease have unique features that should be taken into account when providing care and conducting…
Early Treatment Does Not Worsen the Course of Parkinson’s, Observational Study Finds
Starting treatment earlier does not appear to worsen the course of Parkinson’s disease or be associated with more severe treatment…
COVID-19 Infection May Raise Risk of Parkinson’s, Scientists Say
People who are infected with SARS-CoV2 — the virus that causes COVID-19 — may be at greater risk of…
FDA Supports Cala Trio as Potential Therapy for Action Tremors in Hands
The U.S. Food and Drug Administration (FDA) has named  Cala Trio a breakthrough device as a potential wrist-worn treatment of action tremors in…
Sanofi Supports PD GENEration Initiative to Increase Genetic Testing of Parkinson’s Patients
Sanofi will provide $1 million in research funding over the next two years to support PD GENEration, a…
Neurons in Cell Cultures Form Complicated Networks, Study Shows
Rodent neurons (nerve cells) in cell cultures form complex interaction networks that seem designed to maximize information processing, but are…
Discovery of Key Feature of Alpha-synuclein May Lead to New Treatment Strategies for Parkinson’s
Targeting certain regions of the alpha-synuclein protein could be a viable therapeutic strategy for Parkinson’s disease, a study suggests.